(Q45016195)

8 December 2017

Intracerebral injection of sulfamidase delays neuropathology in murine MPS-IIIA. (English)

1 reference

8 December 2017

2

1 reference

8 December 2017

3

John J Hopwood

1 reference

8 December 2017

Peter S Savas

1

1 reference

8 December 2017

1 August 2004

1 reference

Molecular Genetics and Metabolism

8 December 2017

1 reference

8 December 2017

82

1 reference

8 December 2017

4

1 reference

8 December 2017

273-285

1 reference

Prevalence of lysosomal storage disorders

8 December 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.05.005

A mouse model for mucopolysaccharidosis type III A (Sanfilippo syndrome).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.05.005

A novel missense mutation in lysosomal sulfamidase is the basis of MPS III A in a spontaneous mouse mutant

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.05.005

Glycosaminoglycan accumulation and excretion in the mucopolysaccharidoses: characterization and basis of a diagnostic test for MPS

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.05.005

High-resolution electrophoresis of urinary glycosaminoglycans: an improved screening test for the mucopolysaccharidoses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.05.005

Sulfamidase deficiency in a family of Dachshunds: a canine model of mucopolysaccharidosis IIIA (Sanfilippo A).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.05.005

Mucopolysaccharidosis IIIA (Sanfilippo syndrome) in a New Zealand Huntaway dog with ataxia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.05.005

Caprine mucopolysaccharidosis-IIID: clinical, biochemical, morphological and immunohistochemical characteristics.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.05.005

Enzyme-replacement therapy from birth delays the development of behavior and learning problems in mucopolysaccharidosis type IIIA mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.05.005

The efficacy of enzyme replacement therapy in patients with chronic neuronopathic Gaucher's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.05.005

New prospects for the treatment of lysosomal storage diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.05.005

Neuropsychological outcomes of several storage diseases with and without bone marrow transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.05.005

In utero fetal liver cell transplantation without toxic irradiation alleviates lysosomal storage in mice with mucopolysaccharidosis type VII

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.05.005

Intracerebral transplantation of mesenchymal stem cells into acid sphingomyelinase-deficient mice delays the onset of neurological abnormalities and extends their life span.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.05.005

Chemical chaperones increase the cellular activity of N370S beta -glucosidase: a therapeutic strategy for Gaucher disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.05.005

Therapeutic neonatal hepatic gene therapy in mucopolysaccharidosis VII dogs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.05.005

Functional correction of established central nervous system deficits in an animal model of lysosomal storage disease with feline immunodeficiency virus-based vectors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.05.005

Recombinant human sulphamidase: expression, amplification, purification and characterization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.05.005

Diagnosis of Sanfilippo type A syndrome by estimation of sulfamidase activity using a radiolabelled tetrasaccharide substrate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.05.005

Selective neurodegeneration in murine mucopolysaccharidosis VII is progressive and reversible.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.05.005

Attenuated plasticity in neurons and astrocytes in the mouse model of Sanfilippo syndrome type B.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.05.005

Distribution of a lysosomal enzyme in the adult brain by axonal transport and by cells of the rostral migratory stream.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.05.005

Intravitreal gene therapy reduces lysosomal storage in specific areas of the CNS in mucopolysaccharidosis VII mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.05.005

Intracranial injection of recombinant adeno-associated virus improves cognitive function in a murine model of mucopolysaccharidosis type VII.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.05.005

Neuroaxonal dystrophy in neuronal storage disorders: evidence for major GABAergic neuron involvement.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.05.005

Pathological study of mice with total deficiency of sphingolipid activator proteins (SAP knockout mice).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.05.005

Cerebellar degeneration in the Niemann-Pick type C mouse.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.05.005

Applications of the Morris water maze in the study of learning and memory

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.05.005

Testing the importance of the caudal retrosplenial cortex for spatial memory in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.05.005

Impaired spatial performance in rats with retrosplenial lesions: importance of the spatial problem and the rat strain in identifying lesion effects in a swimming pool.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.05.005

Brain structures and neurotransmitters regulating aggression in cats: implications for human aggression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.05.005

Neurodegeneration: linking ubiquitin/proteasome pathway impairment with inflammation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.05.005

Activated microglia in cortex of mouse models of mucopolysaccharidoses I and IIIB

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.05.005

Molecular pathophysiology in Tay-Sachs and Sandhoff diseases as revealed by gene expression profiling.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.05.005

Ectopic axon hillock-associated neurite growth is maintained in metabolically reversed swainsonine-induced neuronal storage disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.05.005

10.1016/J.YMGME.2004.05.005

7 January 2021

Identifiers

DOI

1 reference

8 December 2017

1 reference

PubMed ID

15308125